Kalaris Reports First Quarter 2025 Financial Results and Provides Business Highlights

Stock Information for Vyant Bio Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Vyant Bio Inc.

Kalaris Reports Second Quarter 2025 Financial Results and Provides Business Updates
ALLOVIR ALERT: Bragar Eagel & Squire, P.C. is Investigating AlloVir, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Kalaris to Present at Noble Capital Markets 2025 Emerging Growth Equity Conference
Kalaris to Participate at Stifel Ophthalmology Forum
Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee
Kalaris Announces Closing of Merger with AlloVir
Kalaris and AlloVir Announce Stockholder Approval of Merger
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALVR, WMPN, IPG, TURN on Behalf of Shareholders

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.